Prognostic Value of Tumor Heterogeneity on 18f-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients Receiving 500 Mg Fulvestrant: A Retrospective Study
Scientific Reports - United Kingdom
doi 10.1038/s41598-018-32745-z
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 27, 2018
Authors
Publisher
Springer Science and Business Media LLC